帕金森病可能的临床诊断方法的发展:与事件相关的潜力
Burcak Yavuz1, Emir Rusen2, Tugce Duman3
1Vocational School of Health Services/Istanbul, Altinbas University, Turkey.
Neurocase
|April 27, 2024
概括
事件相关潜力 (ERP) 分析显示,在深度大脑刺激 (DBS) 后,帕金森病 (PD) 患者的认知能力得到改善. ERP为诊断PD和监测治疗效果提供了一个有希望的,非侵入性的工具.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,通常与认知障碍有关.
- 深度大脑刺激 (DBS) 是PD运动症状的既定治疗方法,但它对认知的影响需要进一步调查.
研究的目的:
- 调查事件相关潜力 (ERP) 分析在检测帕金森病患者认知变化的有用性.
- 评估深度大脑刺激 (DBS) 对PD患者认知功能和注意力技能的影响.
主要方法:
- 利用事件相关潜力 (ERP) 分析和神经心理测试 (NPT) 对85名志愿者,包括PD患者和没有DBS.
- 在不同患者组之间比较ERP延迟和NPT结果,以评估认知状态.
主要成果:
- 在帕金森病 (PD) 组中观察到长时间的ERP延迟,这表明认知障碍.
- 接受深度大脑刺激 (DBS) 的患者表现出减少ERP延迟,症状改善以及增强认知和注意力技能.
结论:
- 事件相关潜力 (ERP) 分析是一种有前途的非侵入性方法,用于评估帕金森病的认知状态.
- 在接受DBS的PD患者中,ERP可能有助于诊断和监测疾病进展和治疗疗效.
更多相关视频
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.2K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.8K
相关概念视频
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:15Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537